The Food and Drug Administration Safety and Innovation Act (FDASIA, P.L. 112-144).

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service.

Language:

English

Subjects (All):

Drugs.

Medical economics.

Medical laws and legislation.

Medical supplies.

Physical Description:

1 online resource (1 online resource (49 p), digital, PDF file)

monochrome

Place of Publication:

[Place of publication not identified] : [publisher not identified], 2012.

System Details:

text file

Summary:

Provides brief policy background narrative and overview of provisions in P.L. 112-144, the Food and Drug Administration Safety and Innovation Act (FDASIA), which reauthorizes FDA authority to collect user fees and amends the Federal Food, Drug, and Cosmetic Act to expand authority of FDA to perform its human drug, biological product, and medical device responsibilities. Summarizes each title of FDASIA.

Notes:

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed May 2014). Reuse except for individual research requires license from ProQuest, LLC.

CRS Report.

Other Format:

Microfiche version: Library of Congress. Congressional Research Service. Food and Drug Administration Safety and Innovation Act (FDASIA, P.L. 112-144)

Access Restriction:

Restricted for use by site license.